Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    9 days ago
    No Change Detected
  2. Check
    16 days ago
    No Change Detected
  3. Check
    24 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a revision label, Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:25:02.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays the latest revision label (v3.4.3) and removes the previous revision (v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-07T13:20:11.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page shows a revision bump from v3.4.1 to v3.4.2 with no changes to study content, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:25:19.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A minor revision update from v3.4.0 to v3.4.1; core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T13:37:56.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Minor UI and text updates: glossary show/hide controls were added, and footer text was updated to reflect capitalization and a new revision tag (v3.4.0).
    Difference
    0.2%
    Check dated 2026-01-23T10:14:44.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive study information or functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-01-16T05:59:56.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.